Jeff Yass’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-268
Closed -$14K 11079
2019
Q2
$14K Sell
268
-846
-76% -$147K ﹤0.01% 10048
2019
Q1
$241K Buy
1,114
+702
+170% +$283K ﹤0.01% 7584
2018
Q4
$143K Sell
412
-30
-7% -$23.3K ﹤0.01% 8020
2018
Q3
$512K Sell
442
-233
-35% -$215K ﹤0.01% 6475
2018
Q2
$577K Buy
675
+325
+93% +$270K ﹤0.01% 6504
2018
Q1
$410K Sell
350
-107
-23% -$118K ﹤0.01% 7030
2017
Q4
$422K Buy
457
+84
+23% +$77.6K ﹤0.01% 6951
2017
Q3
$410K Sell
373
-462
-55% -$525K ﹤0.01% 6863
2017
Q2
$962K Buy
835
+442
+112% +$538K ﹤0.01% 5346
2017
Q1
$454K Buy
393
+277
+239% +$267K ﹤0.01% 6666
2016
Q4
$122K Buy
+116
New +$52.6K ﹤0.01% 8984
2016
Q3
Sell
-273
Closed -$112K 9267
2016
Q2
$112K Buy
+273
New +$134K ﹤0.01% 7968
2016
Q1
Sell
-77
Closed -$44K 9892
2015
Q4
$44K Sell
77
-46
-37% -$32.2K ﹤0.01% 9125
2015
Q3
$109K Sell
123
-580
-83% -$529K ﹤0.01% 9094
2015
Q2
$724K Buy
703
+181
+35% +$212K ﹤0.01% 6873
2015
Q1
$743K Buy
522
+25
+5% +$31.7K ﹤0.01% 6340
2014
Q4
$695K Buy
497
+60
+14% +$86.7K ﹤0.01% 6583
2014
Q3
$535K Buy
437
+217
+99% +$312K ﹤0.01% 7080
2014
Q2
$400K Buy
+220
New +$294K ﹤0.01% 7884

Other funds holding HSTO

Jeff Yass's HSTO Position: Q2 2023 in Review

Jeff Yass sold out of Histogen Inc. Common Stock (HSTO) in Q2 2023, closing a stake of 15,487 shares — an estimated $18.7K sold.

Jeff Yass first reported a position in HSTO in Q3 2014 and held it in 19 quarters. The position peaked at $1.14M in Q3 2018. 13 funds tracked by Wall St. Rank hold HSTO as of Q2 2023.

  • Jeff Yass reported no remaining Histogen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Jeff Yass sold 15,487 Histogen Inc. Common Stock shares in Q2 2023, an estimated $18.7K.
  • Jeff Yass first reported a position in Histogen Inc. Common Stock in Q3 2014 and held it in 19 quarters.
  • Jeff Yass's Histogen Inc. Common Stock position peaked at $1.14M in Q3 2018.
  • 13 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.